Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease.
Sise ME, McQuaid T, Martin P.
Nephrol Dial Transplant. 2022 Nov 23;37(12):2327-2334. doi: 10.1093/ndt/gfab072.
Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease.
Ridruejo E, Mendizabal M, Silva MO.
Hemodial Int. 2018 Apr;22 Suppl 1:S97-S103. doi: 10.1111/hdi.12651.
Hepatitis C.
Liddle C.
Anaesth Intensive Care. 1996 Apr;24(2):180-3. doi: 10.1177/0310057X9602400209.
Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C, Mauro E, Ermacora A, Doretto P, Fumagalli S, Tonizzo M, Toffolutti F, Gattei V.
Minerva Med. 2021 Apr;112(2):175-187. doi: 10.23736/S0026-4806.20.07120-7. Epub 2020 Nov 16.
Is Moderate Alcohol Consumption Safe for Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women?
Lo Re V 3rd.
Clin Infect Dis. 2017 Nov 29;65(12):2057-2059. doi: 10.1093/cid/cix720.
[Chronic hepatitis C: patients with mild disease].
Quer JC, Diago M, Crespo J, García-Samaniego J, Morillas R, Andrade R, Ángel Simón M.
Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30002-9.
Thrombocytopenia in chronic hepatitis C.
Olariu M, Olariu C, Olteanu D.
J Gastrointestin Liver Dis. 2010 Dec;19(4):381-5.
Daclatasvir for the treatment of chronic hepatitis C.
Degasperi E, Aghemo A, Colombo M.
Expert Opin Pharmacother. 2015;16(17):2679-88. doi: 10.1517/14656566.2015.1109631. Epub 2015 Nov 7.
Current therapy for chronic hepatitis C: The role of direct-acting antivirals.
Li G, De Clercq E.
Antiviral Res. 2017 Jun;142:83-122. doi: 10.1016/j.antiviral.2017.02.014. Epub 2017 Feb 24.
Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.
Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G.
J Viral Hepat. 2017 Mar;24(3):187-196. doi: 10.1111/jvh.12630. Epub 2016 Dec 5.
